We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
eBay
EBAY
$46.1B
| $31.9M | 0.04% |
285,700
-44,200
| -13% | -$4.72M |
|
|
GCGR
377
General Catalyst Global Resilience Merger Corp
GCGR
$471M
| $31.8M | 0.04% |
+3,150,000
| New | +$31.7M |
|
378
Wabtec
WAB
$47.4B
| $31.8M | 0.04% |
117,879
-11,742
| -9% | -$3.1M |
|
379
D.R. Horton
DHI
$38.9B
| $31.8M | 0.04% |
195,075
+38,700
| +25% | +$5.78M |
|
380
Autodesk
ADSK
$43.2B
| $31.7M | 0.04% |
163,189
-1,700
| -1% | -$388K |
|
|
HONA
381
Honeywell Aerospace
HONA
$48B
| $31.6M | 0.04% |
+143,145
| New | +$31.6M |
|
|
JAN
382
Janus Living Inc
JAN
$7.27B
| $31.6M | 0.04% |
1,100,000
+450,000
| +69% | +$11.7M |
|
383
Nasdaq
NDAQ
$52.7B
| $31.4M | 0.04% |
398,947
-4,100
| -1% | -$360K |
|
384
Avery Dennison
AVY
$12.9B
| $31.4M | 0.04% |
193,200
+124,200
| +180% | +$20.2M |
|
|
AAC.U
385
Ares Acquisition Corporation III Units
AAC.U
| $31.2M | 0.04% |
+3,105,000
| New | +$31.2M |
|
386
Target
TGT
$71.6B
| $31.1M | 0.04% |
237,779
+160,100
| +206% | +$20.3M |
|
|
BCSS
387
Bain Capital GSS Investment Corp
BCSS
$601M
| $30.8M | 0.04% |
3,000,000
| – | – |
|
|
LCLN
388
Lincoln International
LCLN
$917M
| $30.7M | 0.04% |
+1,284,966
| New | +$30.3M |
|
389
MACOM Technology Solutions
MTSI
$21.9B
| $30.5M | 0.04% |
80,057
+10,000
| +14% | +$3.32M |
|
390
Evergy
EVRG
$18.7B
| $30M | 0.04% |
347,482
-376,900
| -52% | -$31.2M |
|
391
4D Molecular Therapeutics
FDMT
$783M
| $29.9M | 0.04% |
2,249,203
+644,047
| +40% | +$6.28M |
|
|
FTW
392
Presidio Production Co
FTW
$332M
| $29.8M | 0.04% |
2,447,391
-270,000
| -10% | -$3.09M |
|
393
AtaiBeckley Inc
ATAI
$2.7B
| $29.7M | 0.04% |
5,642,758
| – | – |
|
394
Honeywell
HON
$65B
| $29.2M | 0.04% |
130,576
-277,875
| -68% | -$62M |
|
395
Truist Financial
TFC
$61.3B
| $29.2M | 0.04% |
585,364
-104,172
| -15% | -$5.12M |
|
396
Summit Therapeutics
SMMT
$14B
| $29M | 0.04% |
+1,989,591
| New | +$35.3M |
|
397
PayPal
PYPL
$44.6B
| $29M | 0.04% |
671,175
+6,400
| +1% | +$291K |
|
398
Coinbase
COIN
$46.1B
| $29M | 0.04% |
198,200
-1,600
| -0.8% | -$289K |
|
399
Cognizant
CTSH
$26.2B
| $28.9M | 0.04% |
747,350
+93,900
| +14% | +$4.94M |
|
400
LXP Industrial Trust
LXP
$3.58B
| $28.8M | 0.04% |
535,000
-5,000
| -0.9% | -$257K |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.